Longevity Leaders World Congress Transparent 140x
Showcase Presentation

I’m an aspiring biotech or Age Tech entrepreneur - Can I present my work?

You certainly can. The conference will host two investor showcases, the Biotech Showcase and the Life Lab Age Tech Showcase. The showcases are application-only, and all submissions undergo a rigorous selection process.

Learn exactly what investors are looking for

Put your company on the radar of specialist investors

Get the visibility needed to power your fund raising

 

Schedule

Monday 28th October 2019 Applications open
Friday 13th December 2019 Submission deadline closes
Week commencing 27th January 2020 Successful applicants notified
Tuesday 25th February 2020 Programme announced

There is no fee to apply for the Biotech Showcase or Life Lab. Successful applicants are required to register for concession tickets to the conference, see Delegate Packages for full details.

Apply for the Biotech Showcase

Apply for the Life Lab

Applications close Friday 13th December 2019

Biotech Showcase

The Biotech Showcase is for emerging biotech companies and late-stage researchers seeking investment in ageing science and the diseases of ageing therapeutics. Biotech and late-stage researchers are encouraged to apply if they are developing novel products within (but not exclusive to) the following fields:

• Cell senescence
• Gene therapy
• DNA methylation and epigenetics
• Biomarker discovery
• Protein degradation
• Plasma proteomics
• Cancer
• Alzheimer’s disease and dementia
• Parkinson’s disease
• Mitochondria function
• Stem cells or regenerative medicine
• Systems biology and AI applications
• mTOR regulation
• Telomere function
• Metabolomics
• Cardiovascular disease
• Autoimmune diseases
• Inflammation

Biotech Showcase Selection Committee

Laurence Barker, CCBO, DDF, SV Health Managers LLP

Laurence Barker

CCBO, DDF
SV Health Investors
Alexandra Bause, Co-Founder, Apollo Ventures

Alexandra Bause

Co-Founder
Apollo Ventures
Chas Bountra, Chief Scientist, SGC Oxford

Chas Bountra

Chief Scientist
SGC Oxford
Mark Hammond, Founding Partner, Deep Science Ventures

Mark Hammond

Founding Partner
Deep Science Ventures
Fiona de Hemptine, Venture Partner, UCB ventures

Fiona de Hemptine

Venture Partner
UCB ventures
Xinhong Lim, Director, Vickers Venture Partners

Xinhong Lim

Director
Vickers Venture Partners
Natalia Novac, Director, Emerging Technology & Innovation, Eli Lilly & Company

Natalia Novac

Director, Emerging Technology & Innovation
Eli Lilly & Company
Alexandra Tolia, Partner, Fund+

Alexandra Tolia

Partner
Fund+

Life Lab Age Tech Showcase

Supported by: Benchmark 300x150

The Life Lab is for start-ups seeking investment in products and services to facilitate ageing well. Entrepreneurs are encouraged to apply if they are developing novel products within (but not exclusive to) the following fields:

Health
• Incontinence
• Menopause
• Loss of sight or hearing
• Back pain
• Sexual health
• Nutrition
Wealth
• Anti-fraud
• Financial planning
• Legacy planning
• Housing
• Insurance
Tech
• At-home care
• Appliances
• Re-education
• Mobility
• Communication
• Social & leisure


Life Lab Selection Committee

Phil Baylis, CEO of Later Living, Legal & General Capital

Phil Baylis

CEO of Later Living
Legal & General Capital
Yael Benvenisti, CEO, Mediterranean Towers Ventures

Yael Benvenisti

CEO
Mediterranean Towers Ventures
Rachel Carey, Chief Scientist, Zinc

Rachel Carey

Chief Scientist
Zinc
Dominic Endicott, Partner, 4GEN Ventures

Dominic Endicott

Partner
4GEN Ventures
Lorraine Morley, Project Lead, Age Tech, Allia & Age Tech Accelerator 300x

Lorraine Morley

Project Lead, Age Tech
Allia & Age Tech Accelerator
Deepali Nangia, Early Stage Adviser & Angel Investor

Deepali Nangia

Early Stage Adviser & Angel Investor
Heather Roxborough, Partner, Optum Ventures

Heather Roxborough

Partner
Optum Ventures
Jonathan Synett, Chief Investment Officer, NCL Technology Ventures

Jonathan Synett

Chief Investment Officer
NCL Technology Ventures
Max Zamkow, Managing Partner, Third Act Ventures

Max Zamkow

Managing Partner
Third Act Ventures
DOWNLOAD BROCHURE